Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 11/20 | 0.48 |
| ▸ | CNR1 | P21554 | 8/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | CDC25B | P30305 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22977721 | 0.86 | CNR2 (0.44) | CNR2CNR1MEN1NR1I2ALDH1A1 | |
| SCHEMBL22977703 | 0.84 | CNR2 (0.46) | CNR2CNR1MEN1NR1I2ALDH1A1 | |
| SCHEMBL22977710 | 0.76 | CNR2 (0.42) | CNR2CNR1MEN1NR1I2ALDH1A1 | |
| SCHEMBL21178996 | 0.76 | SMN1; SMN2 (0.33) | CNR2CNR1MEN1NR1I2ALDH1A1 | |
| SCHEMBL22977706 | 0.76 | SMN1; SMN2 (0.33) | CNR2CNR1MEN1NR1I2ALDH1A1 | |
| SCHEMBL17224789 | 0.75 | DHFR (0.43) | MEN1ALDH1A1CYP1A2MAPTHPGD | |
| SCHEMBL30576349 | 0.75 | DHFR (0.43) | MEN1ALDH1A1CYP1A2MAPTHPGD | |
| SCHEMBL22977704 | 0.73 | KMT2A (0.44) | MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL22977712 | 0.70 | RAB9A (0.33) | MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL22977708 | 0.70 | RAB9A (0.33) | MEN1ALDH1A1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210045385-A1 | PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES | FMC CORP (US) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210045385-A1 | PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES | CYP1A2, CYP1B1, CYP1A1 | CNR2 504/4885CNR1 630/4885MEN1 4471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.